New Perspectives on the Risk of Secondary Cancers After CAR T-cell Therapy
Amidst an FDA investigation into secondary cancers after CAR T therapy, researchers show the risk is likely minimal.
Category: Research
Amidst an FDA investigation into secondary cancers after CAR T therapy, researchers show the risk is likely minimal.
Researchers examined how the molecular features of Hodgkin lymphomas differ between young and older patients.
Researchers developed a model that uses the gut microbiome to predict if a patient's tumor would have a response...
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
Researchers are making progress on genetic classification of sarcoma tumors, the use of T-cell therapy, and nanomedicine delivery.
Learn about cancer vaccines, including the various types used to treat or prevent cancer, and discover what's on the...
Learn about the types of cancer immunotherapy including immune checkpoint inhibitors, ACT, therapeutic vaccines, and more.
At a recent AACR Special Conference, experts discussed emerging therapeutic options to overcome resistance to Bacillus Calmette-Guérin (BCG).
Researchers at the AACR Annual Meeting 2024 shared how AACR Project GENIE data is helping their studies.
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.